CoChat

Target for Glycemic Control

Open access
Monnier, Louis, Colette, Claude · 2009 · Diabetes Care

The DOI matches its Crossref record, with a small difference in title or year; 41 of the 41 references it cites were found in a registry or an index.

Abstract

It is commonly admitted that the glycemic control of patients with type 2 diabetes proceeds from a complex “alchemy” in which the respective contributions of both fasting and postprandial glucose are still a subject of debate (1). A1C, which remains the gold standard for assessing glucose homeostasis, is an integration of both fasting and postprandial glucose variations over a 3-month period (2). From a mathematical point of view, the theory can be formulated as follows (3): ![Formula][1] where FPG ( t ) and PPG ( t ) are the time courses of fasting and postprandial glucose, respectively. As a consequence, the glycemic control of patients with type 2 diabetes can be schematically depicted by the “glucose triad,” whose components are as follows: A1C, fasting, and postprandial glucose levels. At present, and even though the debate remains wide open, it seems that the best assessment of glycemic control is provided by the determination of the three above-mentioned components. Most recommendations that have been published by medical organizations in different countries take into account the three parameters, even though the position statements differ around the world, but also within the same country (4). ### A tool for integrating the different periods of daytime Whereas many physicians continue to emphasize fasting glucose and A1C to guide management of diabetes, observational studies have indicated that glucose testing at postprandial and postabsorptive time points could play an important role (5,6). For instance, lessons from physiology tell us that humans spend half of their lives in postprandial states (7,8). The postprandial state, with respect to glucose, is defined as a 4-h period that immediately follows ingestion of a meal (7). During this period, dietary carbohydrates are progressively hydrolyzed through several sequential enzymatic actions. Even though the insulin response rapidly reduces the postprandial glucose excursion with a return to baseline levels within <2 h, the overall … [1]: /embed/graphic-1.gif

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dc09-s310

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Duration of the postprandial, postabsorptive, and fasting states. The postprandial and the postabsorptive states last for 4 and 6 h, respectively. Therefore, the cumulative duration of postprandial state is ∼12 h, which is equivalent to a full half-day period of time, and the “real” fasting state is limited to a 3-h time interval at the end of the night.
Figure 1 Duration of the postprandial, postabsorptive, and fasting states. The postprandial and the postabsorptive states last for 4 and 6 h, respectively. Therefore, the cumulative duration of postprandial state is ∼12 h, which is equivalent to a full half-day period of time, and the “real” fasting state is limited to a 3-h time interval at the end of the night.CC BY-NC-ND · PubMed Central
Figure 2 How to translate the “glucose triad” into the trilogy of “sevens.”
Figure 2 How to translate the “glucose triad” into the trilogy of “sevens.”CC BY-NC-ND · PubMed Central
Figure 3 The 24-h recordings from the continuous glucose monitoring system in non–insulin-using type 2 diabetic patients with A1C between 7 and 8%. The patients were divided into two subgroups according to whether plasma glucose at fasting was higher (n = 25) or lower (n = 7) than 126 mg/dl (7 mmol/l).
Figure 3 The 24-h recordings from the continuous glucose monitoring system in non–insulin-using type 2 diabetic patients with A1C between 7 and 8%. The patients were divided into two subgroups according to whether plasma glucose at fasting was higher (n = 25) or lower (n = 7) than 126 mg/dl (7 mmol/l).CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 41 references

Research works printed but not linked: 1

  1. Levy, 1998, Beta-cell deterioration determines the onset and rate of progression of secondary dietary failure in type 2 diabetes mellitus: the 10-year follow-up of the Belfast diet study, Diabet Med, 15, 290, 10.1002/(SICI)1096-9136(199804)15:4<290::AID-DIA570>3.0.CO;2-M · DOI

Cited by

Metadata

Authors
Monnier, L., & Colette, C.
Affiliations
From the Laboratory of Human Nutrition, Institute of Clinical Research, Montpellier, France.
Corresponding author
Monnier, Louis
Venue
Diabetes Care
Published
2009-11-01
Volume
32
Issue
suppl_2
Pages
S199-S204
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2164763907
Cited by
82
References
41
Citations by year
2026: 4 · 2025: 10 · 2024: 5 · 2023: 3 · 2022: 8 · 2021: 5 · 2020: 7 · 2019: 3 · 2018: 9 · 2017: 3 · 2016: 6 · 2015: 6 · 2014: 6 · 2013: 1 · 2012: 2
FWCI
0.26
Type
journal article
Language
en
Open access
Locations
  • Diabetes Care (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
glycemic control, type 2 diabetes, HbA1c, fasting blood glucose, postprandial blood glucose, glycemic targets, insulin response
MeSH terms
Blood Glucose, Circadian Rhythm, Diabetes Mellitus, Type 2, Fasting, Glycated Hemoglobin, Homeostasis, Humans, Hyperglycemia, Insulin, Postprandial Period, Consensus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.